148 related articles for article (PubMed ID: 6380285)
1. Multicenter clinical trial of cefoperazone sodium in the United States.
Cohen MS; Washton HE; Barranco SF
Am J Med; 1984 Jul; 77(1B):35-41. PubMed ID: 6380285
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter study of cefoperazone in Austria].
Forenbacher HH
Wien Med Wochenschr; 1985 Mar; 135(5):123-6. PubMed ID: 3993050
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and tolerability of cefoperazone in patients with nosocomial infections].
Albano O; Palasciano G; Morelli N; Monno D; Velardi A; Tardi S; Malvestiti FM
Clin Ter; 1988 Jul; 126(2):97-100. PubMed ID: 2974382
[No Abstract] [Full Text] [Related]
4. Multicenter clinical trials of cefoperazone in Japan.
Saito A; Ueda Y
Clin Ther; 1984; 7(1):49-59. PubMed ID: 6394129
[TBL] [Abstract][Full Text] [Related]
5. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
[TBL] [Abstract][Full Text] [Related]
6. Asian multicenter trial of cefoperazone in respiratory tract infection.
Matsumoto K; Chung HY; Hsieh WC
Clin Ther; 1984; 6(6):824-38. PubMed ID: 6391668
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter research on cefoperazone efficacy and tolerance in the therapy of urinary and respiratory infections].
Paradisi F; de Crescenzo G; Ruffilli MP
Minerva Med; 1989 Jan; 80(1):43-51. PubMed ID: 2644585
[TBL] [Abstract][Full Text] [Related]
8. Worldwide clinical experience with cefoperazone.
Gerber AU; Craig WA
Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy of cefoperazone sodium in the treatment of infections in intensive therapy].
Fanton G; Spagarino E; Fiorani V; Capellaro L
Minerva Med; 1987 Nov; 78(21):1621-3. PubMed ID: 3683960
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefoperazone in lower respiratory tract infections].
Ishibashi T; Takamoto M; Shinoda A; Matsuba K; Yoshida M; Ichikawa Y; Ando M; Matsuzaki Y; Kitahara Y; Hara N
Jpn J Antibiot; 1986 Oct; 39(10):2780-94. PubMed ID: 3543433
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin: an update on clinical experience.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
13. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
14. Cefoperazone sodium in the treatment of serious bacterial infections in 2,100 adults and children: multicentered trials in Europe, Latin America, and Australasia.
Gordon AJ; Phyfferoen M
Rev Infect Dis; 1983; 5 Suppl 1():S188-99. PubMed ID: 6221390
[TBL] [Abstract][Full Text] [Related]
15. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
[TBL] [Abstract][Full Text] [Related]
18. [Use of cefoperazone in clinical practice].
Strachunskiĭ LS; Prokhorenkov PI; Novikova IuA; Krechikova OI; Iakusheva LV
Antibiot Khimioter; 1992 Aug; 37(8):19-21. PubMed ID: 1456817
[TBL] [Abstract][Full Text] [Related]
19. Moxalactam: clinical summary of efficacy and safety.
Kammer RB
Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with cefoperazone in the field of surgery in Japan.
Shibata K
Clin Ther; 1980; 3(Spec Issue):173-89. PubMed ID: 6446393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
